MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™,MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™,

bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality

2026/02/18 23:01
4 min read

MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining highprecision DNA sequencing, advanced bioinformatics and bioMérieux’s microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve consumer safety.

Every year, microbial spoilage contributes significantly to food waste and quality losses across the global food industry. Scientific estimates indicate that 15–20% of food is wasted after production, and part of the waste is due to spoilage, with microorganisms such as Pseudomonas, aerobic and anaerobic spore‑formers, and fungi playing a major role in both fresh and processed foods and beverages.1

For food manufacturers, these challenges lead to substantial economic losses, reputational risks and operational disruption. Identifying the microorganisms responsible for spoilage, understanding their origin and preventing recurrence remain complex and time‑consuming tasks.

SMARTBIOME™ addresses these challenges through an advanced, accessible platform for in-depth spoilage investigation. The solution combines high‑resolution DNA sequencing with powerful bioinformatics and data science, an exclusive spoilage knowledge base, and bioMérieux’s expert consulting services. Together, these capabilities transform complex microbiological data into clear, actionable insights.

Spot spoilage, act confidently and prevent contamination

The solution enables food manufacturers to accurately identify spoilage organisms at every stage of production, trace issues back to their root cause using data‑driven insights and strengthen process controls. By monitoring microbiological trends over time, manufacturers can anticipate risks and proactively adjust their processes to prevent future spoilage events before they escalate. 

“With SMARTBIOME™, we are giving food manufacturers the ability to understand and control spoilage like never before,” declared Alejo Migones, Senior Vice President, Food Safety & Quality. “By combining our microbiology expertise with powerful data science, we continue to enhance our Augmented Diagnostics approach by helping our customers run healthy and sustainable operations.” 

This innovative solution has been developed in close collaboration with the teams of Neoprospecta, a Brazil‑based genomics and data science company acquired by bioMérieux in January 2025. The teams jointly work in establishing an international reference in technologies and solutions for microorganism analysis, identification and control.

“Through the development of sequencing and datadriven microbiology solutions, we move beyond isolated test results to deliver meaningful, actionable insights. This allows us to support food manufacturers more effectively, helping them improve processes and making bioMérieux a true longterm partner in their microbiological risk management and quality programs. Ultimately, these advances also contribute to delivering safer products to consumers,” added Yasha Mitrotti, Executive Vice President, Industrial Applications, bioMérieux.

SMARTBIOME™ is already available for food manufacturers in several regions worldwide, including North America, Latin America and Europe.

1 Snyder, A.B., Martin, N. & Wiedmann, M. Microbial food spoilage: impact, causative agents and control strategies. Nat Rev Microbiol 22, 528–542 (2024). https://doi.org/10.1038/s41579–024–01037–x  

ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached €4 billion, with over 93% of sales outside of France. 

bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in  agri-food, pharmaceutical and cosmetic products. www.biomerieux.com.  

bioMérieux is listed on the Euronext Paris stock market. 
Symbol: BIM – ISIN Code: FR0013280286
              Reuters: BIOX.PA/Bloomberg: BIM.FP 

CONTACTS
Investors Relations 
Aymeric Fichet
Tel: +33 (0)4 78 87 20 00                   

[email protected]

Media Relations  

Corporate                                 

United States    

France

Romain Duchez

Todd Siesky                       

Isabelle de Segonzac (Image 7) 

Tel: +33 (0)4 78 87 20 00

Tel: +1 919.791.5822

Tel: +33 (0)1 53 70 74 85 

[email protected] 

[email protected]           

[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomerieux-launches-smartbiome-to-help-food-manufacturers-gain-deeper-insights-into-spoilage-and-protect-product-quality-302689937.html

SOURCE bioMérieux

Market Opportunity
Griffin AI Logo
Griffin AI Price(GAIN)
$0.00204
$0.00204$0.00204
-0.29%
USD
Griffin AI (GAIN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Institute of Museum and Library Services Awards $4.1 Million to Support the Trump AI Action Plan

Institute of Museum and Library Services Awards $4.1 Million to Support the Trump AI Action Plan

Museums and libraries across the country will initiate AI literacy and integration projects WASHINGTON, Feb. 18, 2026 /PRNewswire/ — The Institute of Museum and
Share
AI Journal2026/02/19 01:16
Humain takes minority stake in xAI

Humain takes minority stake in xAI

The post Humain takes minority stake in xAI appeared on BitcoinEthereumNews.com. A Saudi-backed AI firm has confirmed a major xai investment that reshapes competitive
Share
BitcoinEthereumNews2026/02/19 01:23
Warsaw Stock Exchange lists its first Bitcoin ETF

Warsaw Stock Exchange lists its first Bitcoin ETF

The post Warsaw Stock Exchange lists its first Bitcoin ETF appeared on BitcoinEthereumNews.com. The Warsaw Stock Exchange has listed its first Bitcoin ETF, offering investors regulated exposure to BTC through futures contracts. Summary The Bitcoin BETA ETF tracks BTC through CME futures and includes a hedging strategy to reduce USD/PLN currency risk. Approved by Poland’s Financial Supervision Authority, the fund is managed by AgioFunds TFI. Bitcoin ETF arrives on Warsaw Stock Exchange The Warsaw Stock Exchange (GPW) has listed its first-ever crypto ETF, the Bitcoin BETA ETF. According to GPW’s official announcement, the Bitcoin BETA ETF does not invest in physical Bitcoin (BTC), but gains exposure through futures contracts traded on the Chicago Mercantile Exchange. To minimize foreign exchange volatility, the fund employs a hedging strategy using forward contracts, insulating investors from fluctuations in the USD/PLN exchange rate. Developed by AgioFunds TFI, the ETF was approved by Poland’s Financial Supervision Authority in June and is backed by Dom Maklerski Banku Ochrony Środowiska S.A. as its market maker. “Offering exposure to Bitcoin through an ETF listed on GPW increases safety of trading, as investors can participate in the cryptocurrency market using an instrument which is supervised, cleared, and subject to the transparency standards applicable to a regulated capital market,” said Michał Kobza, Member of the Management Board of the Warsaw Stock Exchange. The current crypto ETF landscape Globally, Bitcoin ETFs have already gained traction on major exchanges, including Nasdaq, NYSE, and Cboe in the U.S., where a wave of spot Bitcoin ETFs was approved in early 2024. Other prominent markets include the Toronto Stock Exchange in Canada, Germany’s Xetra, Switzerland’s SIX Exchange, Brazil’s B3, and Cboe Australia. These ETFs offer various structures, from physically-backed spot products to futures-based funds, like the one just listed on GPW. Beyond Bitcoin and Ethereum, altcoin ETFs are increasingly gaining traction. According to the latest count by Bloomberg analysts,…
Share
BitcoinEthereumNews2025/09/19 14:30